หน้าแรกประกาศ

ประกาศมาใหม่

ลงประกาศสินค้าใหม่ที่นี่

สมัครสมาชิก

เข้าสู่ระบบสมาชิก

Ibruxen 140mg is a prescription medication containing Ibrutinib, a Bruton’s tyrosine kinase (BTK) inhibitor used in the treatment of certain blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia (WM). It works by blocking BTK, preventing cancer cell growth. Ibruxen 140mg is taken orally as directed by a healthcare professional. Regular monitoring is essential to manage side effects like bleeding risks, infections, and high blood pressure. Always consult a doctor before use.